Led · Seed · Oct 2025

Founded in 2023 by former McKinsey and Goldman Sachs executive Lauren Gage, Triplemoon delivers tech-enabled, fully virtual behavioral health care for children and their families in partnership with primary care providers. Its collaborative care model offers timely access to psychiatrists, psychologists, and social workers who handle diagnosis, behavioral interventions, care coordination, whole-family education, and medication management for conditions such as anxiety, depression, ADHD, autism, and ODD. The platform serves both commercially insured and Medicaid populations, aiming to close the gap in pediatric mental health where 39 million children need support yet only 20 percent receive it. Triplemoon’s approach is grounded in an attachment-informed philosophy that emphasizes early development, play as learning, and strong parent-child relationships. By embedding evidence-based behavioral care into everyday clinical workflows, the company seeks to improve access, outcomes, and economics for families, pediatricians, and payers. Proceeds from its recent seed financing will fuel expansion into priority markets and further develop its tech-enabled clinical ecosystem.

Participated · Series A · Jul 2024

Cypris offers an AI-powered research platform and market intelligence ecosystem designed for R&D and innovation teams. Its platform surfaces LLM-driven insights, semantic search, advanced data monitoring and access to 500M+ global data points. The company also provides bespoke research via a team of data analysts working from a focused technical database. Cypris serves leading Fortune 100 companies, government agencies, universities, and research institutions. The company plans to use the new capital to accelerate scaling of its platform for global R&D teams. Cypris is led by CEO Steve Hafif and is based in New York City. Cypris is a market-intelligence platform built for research, development, and innovation teams that serves as a single ecosystem for global innovation data. Led by CEO Steve Hafif, the platform aggregates and curates a proprietary database of more than 500M global data points, updated daily. Datasets include research papers, patents, product launch news and other major sources, which the platform uses to generate automated, interactive reports. Users can run queries on keywords, competitor names or forward-looking concepts to receive reports on the historical and current status of innovation for fields or companies. The company raised a $4M Series A and intends to use the proceeds to expand development efforts and broaden its business reach. Cypris is based in New York.

Led · Series A · May 2022

KAID Health builds the Whole Chart Analysis™ platform, an NLP-centric solution that integrates structured EMR data and insights distilled from clinical notes using the latest language models. The product collects comprehensive patient data to improve coding accuracy, capture, quality reporting, and care management while reducing clinician and staff burden. KAID's technology is used across leading providers, health systems, academic medical centers, and payers and is proven in commercial settings and peer-reviewed literature. Today it improves Medicare Advantage coding accuracy and completeness for large provider groups across the U.S. and also streamlines chart review for prior authorization, clinical trial enrollment, and preoperative risk identification. With new funding, KAID plans to bolster its market footprint among providers and payer partners and to enable significant service expansion. KAID Health’s core product is a natural language processing–centric Whole Chart Analysis platform that extracts structured and text data from electronic medical records and pushes identified care and coding gaps into provider workflows. The platform can financially reward providers for timely completion of assigned tasks and is used across use cases including Medicare Advantage coding accuracy, automated quality metric reporting, prior authorization chart review, and pre-operative risk identification. KAID sells to and works with providers, health systems, academic medical centers, payers, and Accountable Care Organizations. The company reports that its solution has delivered over 10x return on investment for customers and is built in conjunction with leading provider organizations. With the new financing, KAID plans to bolster its market footprint among providers while furthering collaboration between providers and health plans and ACO partners. The company is based in Boston, MA.

Led · Series A · Sep 2021

CrowdHealth offers an app-based suite of tools that let Community members aggregate crowdsourced funds to pay doctors directly and access a nationwide doctor quality and cost database. The platform includes personalized care advocacy, negotiation and legal services to contest outrageous bills, and access to deeply discounted prescription drugs. CrowdHealth’s stated aim is to eliminate insurance middlemen, reimagine healthcare payment, and empower doctors to make care choices without insurer interference. The company says these measures will help members significantly reduce out-of-pocket expenses compared with healthcare.gov plans. Andy Schoonover is the CEO and founder, and the company is based in Austin, Texas. CrowdHealth has announced a $6 million investment round to support its launch and operations.

Participated · Equity · Jun 2021

Ride Health is a Flatiron District–based medical transit management company whose app enables healthcare providers to book and coordinate rides for patients going to and from appointments. The software integrates with ride-hailing services like Uber and Lyft and tailors transportation based on riders’ medical records and personal preferences. Current customers include health systems such as NYC Health + Hospitals and Memorial Sloan Kettering, as well as programs serving elderly individuals and people with intellectual or developmental disabilities whose trips are paid for by Medicare, Medicaid or grant funding. In 2024, the firm plugged into Unite Us, allowing providers on that social-care referral platform to schedule Medicaid-covered rides under a $7.5 billion 1115 waiver pilot. Ride Health also offers tools for providers that own their own vehicles and drivers and plans to grow this fleet-management line. Founder Imran Cronk describes the addressable market as “enormous,” though the company has not disclosed revenue or user figures. The business has now secured an additional $15 million through extensions of its earlier Series A round, building on the $10 million Series A it raised in 2021.